What is Function Oncology?
Function Oncology operates at the intersection of advanced biotechnology and clinical diagnostics, utilizing a CRISPR-powered platform to conduct personalized functional genomics. By assessing target vulnerabilities directly within clinical samples, the company bridges the gap between raw data and therapeutic efficacy. This methodology allows for the identification of treatment opportunities that remain elusive through traditional genomic sequencing alone. As the industry shifts toward precision medicine, Function Oncology's ability to provide individualized insights positions it as a critical player in the development of next-generation cancer therapies and diagnostic protocols.
How much funding has Function Oncology raised?
Function Oncology has raised a total of $28M across 1 funding round:
Series A
$28M
Series A (2023): $28M with participation from Casdin Capital and Section 32
Key Investors in Function Oncology
Casdin Capital
Casdin Capital is a specialized investment firm focused on the life sciences sector, with a proven track record of backing pioneers in diagnostics and molecular information.
Section 32
Section 32 is a venture capital firm founded by Bill Maris that targets cutting-edge technology and innovative startups at the forefront of scientific advancement.
Undisclosed Investors
What's next for Function Oncology?
With the recent influx of capital, Function Oncology is poised to transition from its current developmental phase into a more robust scaling operation. The strategic roadmap likely includes the expansion of its clinical sample processing capabilities and the deepening of its research into critical disease drivers. By leveraging its CRISPR-based platform, the company aims to shorten the development cycle for novel therapeutics while simultaneously enhancing the precision of patient care. Future growth will be defined by the firm's ability to integrate its functional genomics insights into broader clinical workflows, ultimately establishing a new standard for personalized oncology interventions.
See full Function Oncology company page
